Did you know that problems with getting an erection when aroused can be your body's way of telling you to take a look at your ...

The U.S. Food and Drug Administration has approved Myqorzo (aficamten) for the treatment of adults with symptomatic ...

Increased esophageal hypervigilance and anxiety were associated with worse post-treatment symptoms and poor quality of life ...

Altimmune ALT announced that the FDA has granted Breakthrough Therapy Designation to its lead pipeline candidate, pemvidutide ...

The New Year's Champagne turned flat for Madrigal Pharmaceuticals ( MDGL 5.01%) on Tuesday. Investors traded out of the ...

Discover how High-Intensity Focused Ultrasound (HIFU) treatment is revolutionizing care for prostate cancer and tumours with ...

Alignment on Phase 3 registrational trial parameters confirmed following receipt of minutes from end-of-phase 2 meeting with ...

Altimmune said its therapy, pemvidutide, demonstrated statistically significant resolution of MASH without worsening of fibrosis in a recent Phase 2b trial. The trial results also showed early and ...

The Supreme Court of India's November 2025 judgment in Madras Bar Association v. Union of India (2025) may, at first glance, ...

Understanding what autoimmune diseases are, what triggers them and how they’re treated can be a powerful first step toward ...

This summer, Viva Premium is revisiting the best and biggest stories of 2025. The below story was first published in February ...

The goal is to check their influence on children’s dietary choices: Restricting the reach of commercials, some experts ...